Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Taro Pharmaceutical Industries Ltd (NYSE:TARO)

136.18
Delayed Data
As of May 25
 -1.35 / -0.98%
Today’s Change
122.99
Today|||52-Week Range
157.99
-11.89%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Generic
MARKET CAP
$5.9B

Company Description

Taro Pharmaceutical Industries Ltd. engages in the development, manufacturing, and marketing of prescription and over-the-counter pharmaceutical products. Its products include topical creams, ointments, liquid, capsule, and tablet medications. It also involves in manufacturing and marketing of active drug ingredients for dermatological, cardiovascular and central nervous system therapeutic categories. The company was founded in 1950 and is headquartered in Haifa Bay, Israel.

Contact Information

Taro Pharmaceutical Industries Ltd.
14 Hakitor Street
Haifa Bay Haifa 2624761
P:(724) 847-5700
Investor Relations:

Employees

Shareholders

Other institutional9.14%
Mutual fund holders4.92%
Individual stakeholders10.58%

Top Executives

Kal SundaramChief Executive Officer & Director
Itamar karsentiVice President & Operations Head-Haifa
Michael KalbChief Financial & Accounting Officer, Group VP
Avi AvramoffGlobal Vice President-Research & Development
Stephen ManzanoSecretary, Group Vice President & General Counsel